Literature DB >> 11965473

Gastric remnant carcinoma: reevaluation of screening endoscopy.

C J Gannon1, B Engbrecht, L M Napolitano, B L Bass.   

Abstract

A 67-year-old male presented with complaints of chronic postprandial pain in the epigastric region. The patient had undergone a vagotomy, antrectomy, and loop gastrojejunostomy for peptic ulcer disease 25 years prior. Abdominal computed tomography (CT) revealed markedly thickened walls of the gastric remnant with infiltration of the adjacent fat planes. An esophagogastroscopy demonstrated erythematous, friable remnant mucosa. Gastric biopsies revealed invasive adenocarcinoma. At laparotomy a large tumor mass involving the gastric remnant and the antecolic loop gastrojejunostomy was identified. Further exploration revealed a firm nodule in the left lobe of the liver and several small nodules on the diaphragm and the lesser omentum. Biopsies confirmed metastatic adenocarcinoma at all sites. Curative resection was abandoned. Gastric remnant carcinoma (GRC) typically presents more than 20 years after resection for peptic ulcer disease and has a history of poor survival rates. With increased use of diagnostic endoscopy, GRC has been detected at earlier stages. Recent cohort studies demonstrate that GRC has similar survival rates after stage stratification when compared with primary proximal gastric carcinoma. The increased incidence of GRC in later decades (>20 years) after operation in conjunction with decreasing numbers of patients suggests that screening endoscopy should be considered on a 2- to 5-year basis in this population.

Entities:  

Mesh:

Year:  2001        PMID: 11965473     DOI: 10.1007/s00464-001-4175-0

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  2 in total

1.  Surgical management of gastric stump cancer: a report of 37 cases.

Authors:  Li Chen; Hua Tian; Jian Chen; Zhi-gang He; Si-feng Tao; Gurung Lokesh; Shu-you Peng
Journal:  J Zhejiang Univ Sci B       Date:  2005-01       Impact factor: 3.066

2.  Prediction of onset of remnant gastric cancer by promoter DNA methylation of CDO1/HOPX/Reprimo/E-cadherin.

Authors:  Keita Kojima; Naoko Minatani; Hideki Ushiku; Satoru Ishii; Toshimichi Tanaka; Keigo Yokoi; Nobuyuki Nishizawa; Yosuke Ooizumi; Kazuharu Igarashi; Kei Hosoda; Hiromitsu Moriya; Hiroaki Mieno; Masahiko Watanabe; Keishi Yamashita
Journal:  Oncotarget       Date:  2019-03-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.